address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,fiftyTwoWeekChangePercent,epsTrailingTwelveMonths,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,regularMarketChangePercent,regularMarketPrice,marketState,shortName,longName,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,trailingPegRatio
TvistevAegen 48 C,Umeå,90736,Sweden,46 7 05 78 17 68,https://www.lipigon.se,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease; a gene therapy project for the treatment of the rare disease lipodystrophy; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia. The company was incorporated in 2010 and is based in Umeå, Sweden.",7,"[{'maxAge': 1, 'name': 'Mr. Lars  Öhman', 'age': 67, 'title': 'Business Development Manager & Chairman', 'yearBorn': 1957, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Stefan K. Nilsson', 'age': 45, 'title': 'Co-Founder & CEO', 'yearBorn': 1979, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Hugo  Petit', 'age': 54, 'title': 'Chief Financial Officer', 'yearBorn': 1970, 'exercisedValue': 0, 'unexercisedValue': 0}]",[],86400,4,0.13,0.1325,0.128,0.1545,0.13,0.1325,0.128,0.1545,0.0,0.787,13797619,13797619,1484494,3483065,3483065,0.145,0.15,28604552,0.0752,0.4,2.7803802,0.09771336,0.14473173,0.0,0.0,SEK,False,12182531,-2.62481,126760294,193274000,0.042579997,0.04383,193274000,0.197,0.75126904,1735603200,1767139200,1743379200,-27004000,-0.13,1.184,-0.431,-0.5806452,0.10500872,EQUITY,0.148,0.5,0.5,0.5,0.5,0.0,strong_buy,1,3763000,0.025,-28244000,0,0.676,5.047,10288000,0.067,-0.56918997,-1.06611,-18784000,-45862876,-25916000,-1.82582,-2.7453299,-222.09756,SEK,LPGO.ST,en-US,US,Equity,Delayed Quote,True,HIGH,-58.06452,-0.13,0.050286643,0.51463425,0.0032682717,0.022581583,15,0,0.0 - Strong Buy,False,False,1614585600000,0.018000007,0.128 - 0.1545,Stockholm,1484494,0.0728,0.96808517,0.0752 - 0.4,-0.252,-0.63,13.846159,0.148,PREPRE,Lipigon Pharmaceuticals AB,Lipigon Pharmaceuticals AB (publ),[],1751988596,STO,finmb_224233463,Europe/Stockholm,CEST,7200000,se_market,False,
